UNSPSC 51161526: Dazoquinast

This classification denotes an anti-asthmatic agent with the molecular formula C11H7N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A16F9MIN3Z, chemically known as imidazo(1,2-a)quinoxaline-2-carboxylic acid but generally known as dazoquinast, which bears US NIH Compound Identifier 71146. European Medicines Agency schedules Dazoquinast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06924MIG.

UNSPSC 51161526 Dazoquinast is a Commodity code that describes generic pharmaceutical products distributed through state and local government cooperative purchasing vehicles. State and local procurement under this code centers on establishing multi-source generic drug supply agreements through wholesaler networks to serve health departments, correctional facilities, public health agencies, and other government health-care operations. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a primary issuing body for this category. Cooperative purchasing alliances like MMCAP serve as the dominant procurement mechanism at this code level, allowing multiple states and jurisdictions to aggregate demand and negotiate volume pricing with pharmaceutical manufacturers and their authorized distributors.

Recent activity centers on Minnesota and participating states including Oregon, with MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (Solicitation S1070000015802, due March 26, 2026) representing a representative current opportunity. Vendors responding to MMCAP must establish pricing through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and demonstrate compliance with cGMP and Drug Supply Chain Security Act requirements. The RFP weights price competitiveness at 75 percent, with the remainder distributed across fixed pricing, EDI capability, and administrative fee compliance. Award will establish contracts effective July 1, 2026, with a two-year initial term for new vendors, and vendors must maintain commercial general liability of $5,000,000 per occurrence and network security liability of $2,000,000. No set-aside restrictions are identified in the solicitation, and specific award values are not disclosed.